Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-021548

Chief Financial Officer acquired 66,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lee Sung · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-27 Grant or award : show line 1 in the form +66,500 66,500 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-27 Grant or award : show line 2 in the form Stock Option (Right to Buy) +133,000 133,000 D
Loading xslF345X04/doc4.xml…